The Kidney Beam Trial

  • Research type

    Research Study

  • Full title

    Multicentre prospective single-blind wait-list randomised controlled trial, with nested pilot, of the clinical value and economic evaluation of an online physical and emotional wellbeing resource for the improvement of health-related quality of life in people with chronic kidney disease: The Kidney Beam Trial

  • IRAS ID

    291403

  • Contact name

    Sharlene Greenwood

  • Contact email

    sharlene.greenwood@nhs.net

  • Sponsor organisation

    King’s College Hospital NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NCT04872933

  • Duration of Study in the UK

    2 years, 5 months, 30 days

  • Research summary

    This is a multi-centre single-blind waitlist randomised controlled trial (RCT) that will examine the clinical value and cost-effectiveness of an online physical and emotional wellbeing resource for the improvement of health-related quality of life in people with CKD.

    Physical inactivity and poor mental health are very real concerns for people living with kidney disease, and they report multiple symptoms that impact upon the physical component of health-related quality of life (HRQoL). A decrease in the physical component of HRQoL is independently associated with mortality and morbidity. In people living with end stage kidney disease (ESKD), systematic reviews indicate that a range of exercise training interventions improve physical function and alleviate disability symptoms. The physical component of HRQoL can be targeted with interventions to enhance physical activity, however people living with kidney disease are still not routinely offered specialist physical activity or mental health support in the NHS.

    Kidney Beam is a new wellbeing digital health intervention platform that was developed, and launched, to help people with kidney disease manage their physical and mental health through the Coronavirus 2019 (COVID-19) pandemic, resulting lockdown and beyond. It involves a digital health intervention platform to support people with health conditions to stay physically active. Patients will have access to live-on demand or recorded physical activity classes that they will use for 12 weeks with 2 sessions per week.

    The study aims to recruit 304 patients to participate on the study with over 18 years of age, with any ability, any
    kidney condition, and at any stage of kidney disease.

  • REC name

    London - Bromley Research Ethics Committee

  • REC reference

    21/LO/0243

  • Date of REC Opinion

    13 Apr 2021

  • REC opinion

    Further Information Favourable Opinion